| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $61K | -53.1% |
| R&D Expense | $171.6M | -6.2% |
| SG&A Expense | $52.0M | -22.3% |
| Operating Income | -$358.8M | -45.2% |
| Net Income | -$343.0M | -46.2% |
| EPS (Basic) | -$1.31 | -40.9% |
| EPS (Diluted) | -$1.31 | -40.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $105.6M | -27.5% |
| Short-term Investments | $264.9M | -33.9% |
| Current Assets | $379.6M | -31.6% |
| Total Assets | $490.9M | -34.6% |
| Current Liabilities | $53.8M | +55.8% |
| Total Liabilities | $108.0M | +13.6% |
| Stockholders' Equity | $382.8M | -41.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$162.4M | +0.8% |
| Capital Expenditures | $464K | -82.7% |
| Investing Cash Flow | $122.4M | -33.5% |
| Financing Cash Flow | $1.3M | -23.9% |
| Free Cash Flow | -$162.9M | +2.1% |